Company intelligence / Profile preview

Dante Medical Solutions S.r.l.

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

The company launched its first product "Mind the Gum" in 2015. This is a food supplement in chewing gum form designed to improve concentration and memory and combat mental fatigue. The formulation includes active components for brain health. No clinical trial data is referenced; products are marketed as supplements rather than pharmaceuticals.

Therapeutic areas: Neurology
Modalities: Food supplementsnutraceuticals
Industry: Food & Nutrition

Drug pipeline

4 assets

Mind the Gum

Commercial

Indications: Cognitive enhancement, Mental fatigue

3 more assets in the full pipeline.

Request access →

Partnerships

Farmacia Legnani of Milan collaborated on formulation/design of Mind the GumCenciarini & Co. co-founded and provided seed capital to Dante Medical Solutions.

Beyond the preview

Go deeper on Dante Medical Solutions S.r.l..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dante Medical Solutions S.r.l..

Explore the full profile